arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

PROCEPT BioRobotics Corp

PRCT

$20.25 ▼ -1.42 (-6.55%) at close

7 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Moderately Bearish

auto_awesome

Analytical Summary

PROCEPT BioRobotics Corp faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $1.1B

Dividend Yield —

Revenue Growth 37.2% ↘

Op. Margin -33.7% ↗

ROIC -24.9% ↘

FCF / Share $-1.05 ↗

Trailing P/E —

Price / Book 3.1x

FCF Yield —

Debt / Equity 0.14

info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$308.05M

↑ +37.2% —

Net Income Profit after all expenses

$-95.57M

↓ -4.5% —

Operating Margin Operating profit as % of sales

-33.7%

↑ +21.7% 7th

FCF / Share Free cash flow per share

$-1.05

↑ +47.2% —

Long-Term Debt Long-term obligations

$51.62M

— +0.3% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	37.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+365%)	64.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+711%)	81.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+919%)	117.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1370%)	346.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4234%)	—	—
EPS Growth YoY (%)	1.7% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	21.9% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	-14.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	46.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	74.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-4.5% Weak ↑ Weak Improving Year-over-year change in net income	13.7% Fair ↑ Fair Improving Year-over-year change in net income	-21.5% Weak ↑ Weak Improving Year-over-year change in net income	-45.6% Weak Weak Year-over-year change in net income	-12.9% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	47.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	29.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-50.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	46.8% Excellent Excellent Year-over-year change in free cash flow	73.5% Excellent Excellent Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	60.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	86.7% Excellent Excellent Compound annual revenue growth over 3 years	160.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	109.0% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	-33.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-325%)	-43.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-387%)	-80.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-634%)	-107.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-817%)	-157.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1147%)	—	—
Effective Tax Rate (%) (%)	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
Profit Margin (%) (%)	-31.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-359%)	-40.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-439%)	-77.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-748%)	-116.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1068%)	-173.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1547%)	—	—
FCF Margin (%) (%)	-18.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-46.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-97.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-110.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-168.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.26x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-24.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-21.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-26.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	27.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-20.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-26.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-16.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-37.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-26.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-274%)	-22.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-252%)	-37.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-351%)	-44.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-395%)	-22.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-249%)	29.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+93%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	0.14x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-76%)	0.13x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-79%)	0.18x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-70%)	0.26x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-57%)	0.19x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-69%)	-0.24x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-140%)	—
Interest Coverage (x)	-29.99x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-24.34x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-27.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15.57x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-9.32x Weak Weak Operating income divided by interest expense Optimal: > 5x	-9.09x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-234.89M	$-282.25M	$-205.88M	$-170.65M	$-254.32M	$-55.72M	—
Debt / EBITDA (x)	-0.53x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.56x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.47x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.66x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.98x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.99x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$5.55	$4.31	$2.88	$1.69	$2.09	$2.11	—
Basic EPS, GAAP (USD)	$-1.72	$-1.75	$-2.24	$-1.96	$-3.63	$-14.47	—
Free Cash Flow per Share (USD)	$-1.05	$-1.99	$-2.82	$-1.87	$-3.51	$-13.26	—
Book Value per Share (USD)	$6.50	$7.35	$5.53	$4.44	$6.12	$-38.81	—
Tangible Book Value per Share (USD)	$6.50	$7.35	$5.53	$4.44	$6.12	$-38.81	—
Basic Weighted Avg Shares (shares)	55.54M	52.12M	47.26M	44.40M	16.48M	3.66M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$384.58M	$428.71M	$304.64M	$237.34M	$309.93M	$95.73M	—
LT Debt (USD)	$51.62M	$51.47M	$51.34M	$51.21M	$50.00M	$44.41M	—
Total Equity (USD)	$365.87M	$402.22M	$280.75M	$197.07M	$267.09M	$-182.89M	$-143.84M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$308.05M	$224.50M	$136.19M	$75.01M	$34.47M	$7.72M	—
Depreciation Expense (USD)	$6.39M	$5.23M	—	$2.84M	$3.32M	$2.86M	—
Net Income, GAAP (USD)	$-95.57M	$-91.41M	$-105.90M	$-87.15M	$-59.85M	$-53.02M	—
Operating Cash Flow (USD)	$-48.98M	$-99.21M	$-108.00M	$-80.38M	$-57.33M	$-48.34M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 27 quarters

PROCEPT BioRobotics Corp

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare PRCT with peers